Literature DB >> 15823094

Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli.

Mariarita Bertoldi1, Barbara Cellini, Douglas V Laurents, Carla Borri Voltattorni.   

Abstract

MalY from Escherichia coli is a bifunctional dimeric PLP (pyridoxal 5'-phosphate) enzyme acting as a beta-cystathionase and as a repressor of the maltose system. The spectroscopic and molecular properties of the holoenzyme, in the untreated and NaBH4-treated forms, and of the apoenzyme have been elucidated. A systematic study of the urea-induced unfolding of MalY has been monitored by gel filtration, cross-linking, ANS (8-anilino-1-naphthalenesulphonic acid) binding and by visible, near- and far-UV CD, fluorescence and NMR spectroscopies under equilibrium conditions. Unfolding proceeds in at least three stages. The first transition, occurring between 0 and 1 M urea, gives rise to a partially active dimeric species that binds PLP. The second equilibrium transition involving dimer dissociation, release of PLP and loss of lyase activity leads to the formation of a monomeric equilibrium intermediate. It is a partially unfolded molecule that retains most of the native-state secondary structure, binds significant amounts of ANS (a probe for exposed hydrophobic surfaces) and tends to self-associate. The self-associated aggregates predominate at urea concentrations of 2-4 M for holoMalY. The third step represents the complete unfolding of the enzyme. These results when compared with the urea-induced unfolding profiles of apoMalY and NaBH4-reduced holoenzyme suggest that the coenzyme group attached to the active-site lysine residue increases the stability of the dimeric enzyme. Both holo- and apo-MalY could be successfully refolded into the active enzyme with an 85% yield. Further refolding studies suggest that large misfolded soluble aggregates that cannot be refolded could be responsible for the incomplete re-activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823094      PMCID: PMC1180740          DOI: 10.1042/BJ20050279

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Refolding and reactivation of Escherichia coli tryptophan synthase beta2 subunit after inactivation and dissociation in guanidine hydrochloride at acidic pH.

Authors:  C Groha; P Bartholmes; R Jaenicke
Journal:  Eur J Biochem       Date:  1978-12

2.  Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers.

Authors:  J London; C Skrzynia; M E Goldberg
Journal:  Eur J Biochem       Date:  1974-09-01

3.  The tryptophanase from Escherichia coli K12. 3. Further characterization of hybrids between the apo- and holoenzyme.

Authors:  C Skrzynia; J London; M E Goldberg
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

4.  The tryptophanase from Escherichia coli K-12. II. Comparison of the thermal stabilities of apo-, holo-, and hybrid enzymes.

Authors:  O Raibaud; M E Goldberg
Journal:  J Biol Chem       Date:  1973-05-25       Impact factor: 5.157

Review 5.  Protein denaturation.

Authors:  C Tanford
Journal:  Adv Protein Chem       Date:  1968

6.  Conformational properties and catalytic function of aspartate aminotransferase.

Authors:  V I Ivanov; A L Bocharov; M V Volkenstein; M Y Karpeisky; S Mora; E I Okina; L V Yudina
Journal:  Eur J Biochem       Date:  1973-12-17

7.  A comparative study of the thermal inactivation of the isolated and associated domains within the beta 2 subunit of Escherichia coli tryptophan synthetase. Evidence for strong interdomain interactions.

Authors:  C R Zetina; M E Goldberg
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

8.  The C-terminal domain of dimeric serine hydroxymethyltransferase plays a key role in stabilization of the quaternary structure and cooperative unfolding of protein: domain swapping studies with enzymes having high sequence identity.

Authors:  Anant Narayan Bhatt; M Yahiya Khan; Vinod Bhakuni
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

9.  Differential scanning calorimetry of cytoplasmic aspartate transaminase.

Authors:  A Relimpio; A Iriarte; J F Chlebowski; M Martinez-Carrion
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

10.  The nature of the rate-limiting steps in the refolding of the cofactor-dependent protein aspartate aminotransferase.

Authors:  Juan A Osés-Prieto; Maria T Bengoechea-Alonso; Antonio Artigues; Ana Iriarte; Marino Martinez-Carrión
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  5 in total

1.  X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).

Authors:  David F Bishop; Vassili Tchaikovskii; A Victor Hoffbrand; Marie E Fraser; Steven Margolis
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

2.  The mechanism of addition of pyridoxal 5'-phosphate to Escherichia coli apo-serine hydroxymethyltransferase.

Authors:  Francesca Malerba; Andrea Bellelli; Alessandra Giorgi; Francesco Bossa; Roberto Contestabile
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

3.  Biochemical properties and oxalate-degrading activity of oxalate decarboxylase from bacillus subtilis at neutral pH.

Authors:  Carolina Conter; Elisa Oppici; Mirco Dindo; Luigia Rossi; Mauro Magnani; Barbara Cellini
Journal:  IUBMB Life       Date:  2019-02-26       Impact factor: 3.885

Review 4.  Extrinsic fluorescent dyes as tools for protein characterization.

Authors:  Andrea Hawe; Marc Sutter; Wim Jiskoot
Journal:  Pharm Res       Date:  2008-01-03       Impact factor: 4.200

5.  Engineering a pyridoxal 5'-phosphate supply for cadaverine production by using Escherichia coli whole-cell biocatalysis.

Authors:  Weichao Ma; Weijia Cao; Bowen Zhang; Kequan Chen; Quanzhen Liu; Yan Li; Pingkai Ouyang
Journal:  Sci Rep       Date:  2015-10-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.